Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Vectibix (panitumumab; Amgen/Takeda) Drug Analysis 2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 15 Feb 18

The "Drug analysis: Vectibix" drug pipelines has been added to ResearchAndMarkets.com's offering.

Drug Overview

Vectibix (panitumumab; Amgen/Takeda) is a fully human immunoglobulin G2 monoclonal antibody that binds to the extracellular domain of the epidermal growth factor receptor (EGFR). This prevents the activation of EGFR and halts the cascade of intracellular signals dependent on this receptor. Preclinical studies have shown that Vectibix results in inhibition of cell growth, induction of apoptosis, decreased pro-inflammatory cytokine and vascular growth factor production, and internalization of the EGFR.

Product Profiles

List of Figures

Figure 1: Vectibix for colorectal cancer - SWOT analysis

Figure 2: Drug assessment summary of Vectibix for colorectal cancer

Figure 3: Drug assessment summary of Vectibix for colorectal cancer

Figure 4: Vectibix sales for colorectal cancer across the US, Japan, and five major EU markets, by country, 2016-25

List of Tables

Table 1: Vectibix drug profile

Table 2: Overview of major approvals for Vectibix in colorectal cancer

Table 3: Vectibix pivotal trial data in colorectal cancer

Table 4: Vectibix early-phase data in colorectal cancer

Table 5: Vectibix sales for colorectal cancer across the US, Japan, and five major EU markets, by country ($m), 2016-25

Table 6: Patients treated with Vectibix in the US, Japan, and five major EU markets, by country, 2016-25

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/pgjplg/vectibix?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180215006104/en/

Business Wire
www.businesswire.com

Last updated on: 15/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.